Sanara MedTechvsThermo Fisher Scientific

SMTI and TMO stock compared: price, dividend, valuation and results, from SEC filings.

SMTI

Sanara MedTech Inc.

$32.73

Value $300M

+0.00%
SMTI's page

TMO

Thermo Fisher Scientific Inc

$692.74

Value $257B

+0.87%
TMO's page

Sanara MedTech (SMTI) has a market value of $300M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, SMTI moved +55.3% and TMO +22.6%. Dividend yield: SMTI none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SMTI$300M

    TMO$257B

    TMO is 858 times SMTI

  • Revenue, 12 months

    SMTI$112M

    TMO$47.4B

    TMO is 423 times SMTI

  • Net income, 12 months

    SMTI-$3.0M

    TMO$7.1B

  • Operating margin

    SMTI5.6%

    TMO17.9%

    12.3 points apart

  • ROIC

    SMTI9.3%

    TMO8.2%

    1.1 points apart

  • P/E

    SMTI–

    TMO36.4

  • Dividend yield

    SMTI0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    SMTI-2.0%

    TMO+10.3%

    12.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SMTI-2.0%

TMO+10.3%

5010015020222023202420252026
Returns by period
PeriodSMTIWith dividendsTMOWith dividends
1 year since November 17, 2025+55.3%Price +55.3%+22.6%Price +22.1%
3 years since November 17, 2023-1.1%-0.4% a yearPrice -1.1%+50.0%+14.5% a yearPrice +48.5%
5 years since November 17, 2021-2.0%-0.4% a yearPrice -2.0%+10.3%+2.0% a yearPrice +8.7%
10 years since November 18, 2016+554.6%+20.7% a yearPrice +554.6%+388.7%+17.2% a yearPrice +375.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SMTISanara MedTechTMOThermo Fisher Scientific

Valuation

SMTITMO
Valuation
Price$32.73$692.74
Market value$300M$257B
Enterprise value (EV)–$293B
P/E–36.4
P/E, 5-year median–32.7
P/B39.14.7
EV/EBIT–34.6
Free cash flow yield2.4%2.9%

Results and growth

SMTITMO
Results and growth
Revenue, 12 months$112M$47.4B
Net income, 12 months-$3.0M$7.1B
Free cash flow, 12 months$7.3M$7.6B
Earnings per share, 12 months-$3.72$18.96
Revenue growth, year on year19.0%3.9%
Revenue growth a year, past+45.9%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

SMTITMO
Margins and returns on capital
Gross margin93.0%–
Operating margin5.6%17.9%
Net margin-2.7%14.9%
ROIC9.3%8.2%
ROE-43.4%13.4%

Balance sheet

SMTITMO
Balance sheet
Cash$17M$6.1B
Total debt–$41.4B
Net debt / EBITDA–3.7
Interest cover0.9×5.5×

Dividends and buybacks

SMTITMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SMTI or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Sanara MedTech or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 857.7 times Sanara MedTech ($300M), at today's prices.

How did SMTI and TMO stock do over the last 10 years?

Since November 18, 2016, SMTI's price moved +554.6% and TMO's +375.1%. With dividends: SMTI +554.6% (+20.7% a year), TMO +388.7% (+17.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, SMTI or TMO?

The dividend yield at today's price is none for Sanara MedTech and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Sanara MedTech or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -2.7% for Sanara MedTech and 14.9% for Thermo Fisher Scientific, and the operating margin 5.6% and 17.9%. Revenue was $112M and $47.4B.

Which is the better investment, Sanara MedTech or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.